TK
Thomas K Equels bought $5K of AIM stock
Thomas K Equels, CEO & President of AIM ImmunoTech Inc. (AIM), bought 39,000 shares of AIM stock worth $5K, per an SEC Form 4 filed Nov 12, 2026.
It was an open-market purchase.
The trade happened on Nov 10, 2026, 2 days before it was made public.
AIM has moved +3.8% since the trade date, from $0.14 to $0.14 (Nov 13, 2026 close).
- Traded
- Nov 10, 2026
- Disclosed
- Nov 12, 2026
- Filing delay
- 2 days
- Price since
- +3.8%
- Role
- CEO & President
- Source
- SEC Form 4